Market Movers (8-K)
See all →NYSE
CTVA
Corteva, INCCorteva, Inc. reported its third-quarter 2026 financial results, detailing the completion of its Vylor Inc. seed business spin-off and ongoing operational performance.
Worse than expected
NYSE
CTVA
Corteva, INCCorteva, Inc. announced its third-quarter 2026 financial results, reporting a decline in net sales and earnings, while updating its full-year outlook to reflect weaker market conditions, particularly in Brazil.
Worse than expected
NYSE
CTVA
Corteva, INCCorteva and EIDP, Inc. are subject to a temporary restraining order following litigation challenging their separation into two independent companies.
NYSE
CTVA
Corteva, INCCorteva, Inc. has completed its separation into two independent companies, spinning off its seed operating segment into Vylor Inc., and has appointed new directors and officers.
NYSE
CTVA
Corteva, INCCorteva, Inc.'s subsidiary, EIDP, Inc., has successfully completed an exchange offer and consent solicitation for its outstanding senior notes, resulting in a reduction of its total outstanding debt.
NYSE
CTVA
Corteva, INCCorteva, Inc. and Vylor Inc. have executed an Intellectual Property Matters Agreement, detailing the licensing and ownership of intellectual property following their separation.
Quarterly Earnings (10-Q)
See all →NYSE
CTVA
Corteva, INCCorteva, Inc. reported a 6% decrease in Q3 2026 net sales compared to the prior year, impacted by lower volumes and pricing, while also completing the separation of its Seed Business into Vylor Inc.
Worse than expected
NYSE
CTVA
Corteva, INCCorteva, Inc. announced its second quarter 2026 financial results, showing a slight decrease in net sales but an increase in operating EBITDA, while managing ongoing restructuring and legal matters.
NYSE
CTVA
Corteva, INCCorteva reported strong Q1 2026 growth with net sales up 11% to $4.9 billion while advancing its planned business separation.
NYSE
CTVA
Corteva, INCCorteva reports strong third-quarter and year-to-date 2025 financial results, driven by volume growth and cost efficiencies, alongside a plan to separate its Seed and Crop Protection businesses.
Capital raise
Better than expected
NYSE
CTVA
Corteva, INCCorteva, Inc. reported a significant increase in net income and earnings per share for the second quarter and first half of 2025, driven by strong volume growth, strategic pricing, and cost efficiencies.
Capital raise
Better than expected
NYSE
CTVA
Corteva, INCCorteva's Q1 2025 earnings surged despite a slight sales decrease, fueled by strategic pricing in the Seed segment and effective cost management initiatives.
Better than expected
Annual Reports (10-K)
NYSE
CTVA
Corteva, INCCorteva, Inc. reported significant financial improvements in 2025, including a 3% net sales increase and a 14% rise in operating EBITDA, while announcing plans to separate its Seed and Crop Protection businesses into two independent public companies by late 2026.
Better than expected
Capital raise
NYSE
CTVA
Corteva, INCCorteva's 2024 results show a slight dip in net sales due to pricing pressures in crop protection, offset by volume increases in seed and cost-saving measures.
Worse than expected
NYSE
CTVA
Corteva, INCCorteva, Inc. and its subsidiary EIDP, Inc. have released their combined 2023 annual results, showing a slight decrease in net sales but an increase in operating EBITDA.
Worse than expected
Insider Trading (Form 4)
See all →NYSE
CTVA
Corteva, INCChristopher J. Policinski, a Director of Corteva, Inc., received 2,792 shares of common stock on October 30, 2026.
NYSE
CTVA
Corteva, INCNayaki R Nayyar, a Director of Corteva, Inc., received 2,792 shares of common stock on October 30, 2026.
NYSE
CTVA
Corteva, INCJanet Plaut Giesselman, a Director of Corteva, Inc., received 666 shares of common stock on October 30, 2026.
NYSE
CTVA
Corteva, INCBrian Titus, See Remarks of Corteva, Inc., reported multiple transactions in common stock on October 1, 2026.
NYSE
CTVA
Corteva, INCLuther C Kissam Iv, Chief Executive Officer of Corteva, Inc., reported a transaction in 127,949 shares of common stock on October 1, 2026.
NYSE
CTVA
Corteva, INCJennifer Amy Johnson, SVP, Chief Legal Officer of Corteva, Inc., reported a transaction in 446 shares of common stock on September 15, 2026.
Proxy Statements (Def-14A)
NYSE
CTVA
Corteva, INCCorteva, Inc. announces solid 2025 financial results, significant shareholder returns, and proposes a refreshed board slate for its upcoming April 28, 2026 Annual Stockholder Meeting.
Better than expected
NYSE
CTVA
Corteva, INCCorteva, Inc. is soliciting stockholder votes on the election of directors, approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as its independent auditor for 2025.
NYSE
CTVA
Corteva, INCCorteva's 2025 proxy statement outlines key agenda items for the annual stockholder meeting, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor.
NYSE
CTVA
Corteva, INCDEFA14A: Corteva Inc. Sets Date for 2024 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Corteva Inc. announces its 2024 Annual Meeting of Stockholders, urging investors to vote on key proposals including the election of directors, executive compensation, and ratification of the company's accounting firm.
NYSE
CTVA
Corteva, INCCorteva, Inc. releases its proxy statement outlining the agenda for the 2024 Annual Stockholder Meeting, including director elections, executive compensation approval, and a certificate of incorporation amendment.
Schedule 13G - Passive Investments
See all →NYSE
CTVA
Corteva, INCSCHEDULE: FMR LLC Discloses 10.3% Stake in Corteva
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 68,966,497.27 shares, representing 10.3% of Corteva Inc.'s common stock.
NYSE
CTVA
Corteva, INCSCHEDULE: FMR LLC Reports 8.4% Stake in Corteva
FMR LLC, through its affiliates, has disclosed beneficial ownership of 8.4% of Corteva Inc.'s common stock as of September 30, 2026.
NYSE
CTVA
Corteva, INCCapital World Investors has disclosed a beneficial ownership of 6.6% in Corteva, Inc., holding 43,841,218 shares.
NYSE
CTVA
Corteva, INCCapital World Investors has reported beneficial ownership of 36,863,390 shares, representing 5.5% of Corteva, Inc.'s common stock as of March 31, 2026.
NYSE
CTVA
Corteva, INCFMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.2% of Corteva Inc.'s common stock as of March 31, 2026.
NYSE
CTVA
Corteva, INCVanguard Capital Management has reported a beneficial ownership of 7.56% in Corteva Inc. common stock as of March 31, 2026.